CIPLA
Back to All Ratios
|
CIPLA Last 5 Year Current Ratio History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Current Ratio(x) | 4.24 | 3.70 | 3.34 | 2.99 | 2.87 |
What is the latest Current Ratio ratio of CIPLA ?
Year | Current Ratio |
---|---|
Mar2025 | 4.24 |
Mar2024 | 3.70 |
Mar2023 | 3.34 |
Mar2022 | 2.99 |
Mar2021 | 2.87 |
How is Current Ratio of CIPLA Trending?
Years | Current Ratio | % Change | |
---|---|---|---|
Mar2025 | 4.24 | 14.59 | |
Mar2024 | 3.7 | 10.78 | |
Mar2023 | 3.34 | 11.71 | |
Mar2022 | 2.99 | 4.18 | |
Mar2021 | 2.87 | - |
Other Financial Ratios of CIPLA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Quick Ratio Interest Cover Total Debt/Mcap |
Compare Current Ratio ratio of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹121,021.7 Cr | -0.3% | 0.9% | -3.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹398,686.0 Cr | 0.8% | -1.3% | 10.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,075.0 Cr | 1.5% | 2.3% | 47.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,971.0 Cr | -0.1% | 7.2% | 11.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,121.0 Cr | -2.7% | -0.3% | 9.9% | Stock Analytics | |
MANKIND PHARMA | ₹94,907.0 Cr | -2.3% | -5.5% | 3.4% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -0.3% |
0.9% |
-3.8% |
SENSEX | 0.1% |
1.2% |
6% |
You may also like the below Video Courses